Coherus BioSciences, Inc.
Coherus BioSciences, Inc., a leading biotechnology firm headquartered in the United States, focuses on the development and commercialisation of innovative biologic therapies. Founded in 2010, the company has made significant strides in the biosimilars market, particularly in oncology and autoimmune diseases. With a robust portfolio that includes products like Udenyca, Coherus stands out for its commitment to providing high-quality, cost-effective alternatives to expensive biologic treatments. The company operates primarily in North America, with a growing presence in international markets. Recognised for its scientific expertise and strategic partnerships, Coherus BioSciences has established a strong market position, contributing to the accessibility of essential therapies for patients worldwide.
DitchCarbon Score
How does Coherus BioSciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Coherus BioSciences, Inc.'s score of 18 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Coherus BioSciences, Inc.'s reported carbon emissions
Coherus BioSciences, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or initiatives outlined in their climate commitments. Without concrete figures or defined goals, it is challenging to assess their current impact on climate change or their strategic approach to carbon emissions reduction. As a biopharmaceutical company, Coherus may be operating within an industry context that increasingly prioritises sustainability and climate action, but specific commitments or achievements in this area remain unspecified.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Coherus BioSciences, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
